Oncotelic Therapeutcs Inc (OTLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3 | 1,058 | 1,966 | 233 | 1,115 |
| Other current assets | 0 | 0 | 0 | 171 | 0 |
| TOTAL | $3 | $1,149 | $2,066 | $404 | $1,137 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 2 |
| Investments And Advances | 1,769 | 0 | 0 | 0 | 0 |
| Intangibles | 976 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 33 | 33 | 33 |
| TOTAL | $2,745 | $N/A | $33 | $33 | $35 |
| Total Assets | $2,748 | $1,149 | $2,099 | $437 | $1,172 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 283 | 772 | 1,221 | 1,164 | 788 |
| Accrued Expenses | N/A | 119 | 168 | 113 | 582 |
| TOTAL | $283 | $1,091 | $1,561 | $1,524 | $1,649 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $283 | $1,091 | $1,561 | $1,524 | $1,649 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,420 | 41,420 | 41,420 | 41,420 | 41,170 |
| Common Shares | 68 | 414 | 414 | 265 | 265 |
| Retained earnings | -5,490 | -294,386 | -293,711 | -293,069 | -292,275 |
| TOTAL | $2,465 | $58 | $538 | $-1,087 | $-477 |
| Total Liabilities And Equity | $2,748 | $1,149 | $2,099 | $437 | $1,172 |